| Active ingredient (INN) | Aflibercept |
|---|---|
| Brand names | Eylea, Yesafili |
| ATC level 5 | L01XX44 |
| ATC level 4 | L01XX |
| Therapeutic category | Auto-created by Health Canada — Drug Shortages Database scraper |
| Controlled substance | No |
| Marketing-authorisation holders | Bayer Australia Ltd |
| Registrations on file | 2 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| EYLEA aflibercept | 114.3 mg | — | 🇦🇺 AU | Bayer Australia Ltd | Active |
| EYLEA aflibercept | 40 mg | — | 🇦🇺 AU | Bayer Australia Ltd | Active |